The present invention related to methods for treating neurological-urological conditions, including neurogenic bladder dysfunction. This is accomplished by administration of a botulinum toxin into the lower urinary tract of a patient with a neurogenic bladder dysfunction, including the bladder or urinary sphincter and the bladder wall.

 
Web www.patentalert.com

< USE OF OLIGOSACCHARIDES TO STIMULATE BETA-ENDORPHIN PRODUCTION

> Use of a cosmetic compound for promoting skin depigmentation

~ 00475